Literature DB >> 22085273

Carnitine administration reduces cytokine levels, improves food intake, and ameliorates body composition in tumor-bearing rats.

Alessandro Laviano1, Alessio Molfino, Marilia Seelaender, Teresa Frascaria, Giuseppe Bertini, Cesarina Ramaccini, Maria Rosa Bollea, Gennaro Citro, Filippo Rossi Fanelli.   

Abstract

Increased cytokine expression contributes to the pathogenesis of cancer anorexia?cachexia syndrome. Carnitine may reduce inflammation in chronic diseases. We tested the effects of L-propionylcarnitine (PC group) or saline (C group) on food intake (FI), body composition, and inflammatory status of MCA-sarcoma-bearing rats. On tumor appearance, rats were randomly assigned to daily i.p. injection of L-propionylcarnitine (250 mg/kgBW/d; n = 8) or saline (equal volume; n = 8). FI and fat-free mass wasting improved in PC rats only (p < .01 vs. controls). Cytokines? levels decreased in PC rats vs. controls (p < .02). Results suggest that carnitine may ameliorate cancer anorexia?cachexia, via reduction of the inflammatory status.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22085273     DOI: 10.3109/07357907.2011.626476

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  7 in total

1.  Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.

Authors:  Z Altun; Y Olgun; P Ercetin; S Aktas; G Kirkim; B Serbetcioglu; N Olgun; E A Guneri
Journal:  Cell Prolif       Date:  2013-11-29       Impact factor: 6.831

2.  L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.

Authors:  Ricardo A Cruciani; Jenny J Zhang; Judith Manola; David Cella; Bilal Ansari; Michael J Fisch
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

Review 3.  Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Authors:  Robert Ringseis; Janine Keller; Klaus Eder
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

Review 4.  Cancer-induced muscle wasting: latest findings in prevention and treatment.

Authors:  Zaira Aversa; Paola Costelli; Maurizio Muscaritoli
Journal:  Ther Adv Med Oncol       Date:  2017-03-08       Impact factor: 8.168

5.  Cancer anorexia: hypothalamic activity and its association with inflammation and appetite-regulating peptides in lung cancer.

Authors:  Alessio Molfino; Alessandro Iannace; Maria Chiara Colaiacomo; Alessio Farcomeni; Alessandra Emiliani; Gianfranco Gualdi; Alessandro Laviano; Filippo Rossi Fanelli
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-10-05       Impact factor: 12.910

6.  Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.

Authors:  Srinivas Sonne; Prem S Shekhawat; Dietrich Matern; Vadivel Ganapathy; Leszek Ignatowicz
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

Review 7.  Contribution of Neuroinflammation to the Pathogenesis of Cancer Cachexia.

Authors:  Alessio Molfino; Gianfranco Gioia; Filippo Rossi Fanelli; Alessandro Laviano
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.